Latest News

Cancer Killers

Fusion Pharmaceuticals Announces Investment from Canada Pension Plan Investment Board

13th January 2020

Hamilton, ON & Boston, MA – January 13, 2020 – Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinical-stage precision oncology company developing next-generation radiopharmaceuticals, today announced an investment commitment of up to US$20 million from Canada Pension Plan Investment Board […]

Read More
Quanta News

Quanta Announces Collaboration with B. Braun Avitum UK Ltd

13th January 2020

Alcester, Warwickshire, UK, 13 January 2020: Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology company that has developed a personal haemodialysis system called SC+, today announced that it has entered into an agreement with […]

Read More
Pq Bypass News 2

CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial

6th January 2020

Seroba’s portfolio company, PQ Bypass Inc, a medical device company bringing new advancements to the treatment of peripheral artery disease (PAD), has announced that it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for […]

Read More
Cordella PA Sensor Coin

Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System

19th November 2019

LISLE, IL – November 18, 2019 – Seroba’s portfolio company, Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), presented positive first-in-human data of the Cordella™ Pulmonary Artery (PA) Pressure Sensor […]

Read More
Treating Heart Failure

Endotronix Announces Partnership with Tyndall National Institute.

15th October 2019

DUBLIN, IRELAND – October 15, 2019 – Seroba’s portfolio company, Endotronix Ireland Limited, a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced today an Enterprise Ireland Industry Partnership project in a collaboration […]

Read More
Pq Bypass News 2

PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study.

8th October 2019

MILPITAS, Calif. & Dublin, Ireland.  October 8, 2019. PQ Bypass Announces Unconditional IDE Approval from U.S. FDA to Start TORUS SFA Stent Graft Pivotal Study (TORUS-2) Seroba’s portfolio company, PQ Bypass, Inc., a clinical-stage medical device company, today announced it […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top